Thrombocytopenia and its Correction by Platelet Concentrates

Bayer W.L. Bodensteiner D.C. Tilzer L.L. Adams M.E. : Use of platelets and other transfusion products in patients with malignancy. Semin Thromb Haemost, 18: 380–391, 1992.

National Institutes of Health Consensus Conference. Platelet transfusion therapy. Transfus Med Rev, 1: 195–200, 1987.

Slichter S.J. : Principles of platelet transfusion therapy. In: Hematology. Basic principles and practice, Hoffman R , Benz EJ Jr. , Furie S.J. B Shattil , Cohen HJ (Eds), pp 1610–1622, Churchill Livingstone, New York, 1991.

Gaydos L.A. Freireich E.J. Mantel N. : The quantitative relation between platelet counts and hemorrhage in patients with acute leukemia, N Engl J Med, 266: 905–909, 1962.

Heyman M.R. Schiffer C.A. : Platelet transfusion therapy for the cancer patient. Semin Oncol, 17: 198–209, 1990.

Slichter S.J. Harker L.A. : Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol, 7: 523–528, 1978.

Sacher R.A. Luban N.L.C. Strauss R.G. : Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev, 3: 39–54, 1989.

British Committee for Standards in Haematology. Guidelines for platelet transfusion. Transfus Med, 2: 311–318, 1992.

The Royal College of Physicians of Edinburgh. Consensus conference. Leucocyte depletion of blood and blood components. Edinburgh, 1993.

Norfolk D.R. Ancliffe P.J. Contreras M. Hunt B.J. Machin S.J. Murphy W.G. Williamson L.M. Consensus conference on platelet transfusion, Royal College of Physicians of Edinburgh, 27–28 November 1997. Synopsis of background papers. Br J Haematol, 101: 609–617, 1998.

Rebulla P. : Rischio emorragico e trasfusione di piastrine. In: II rischio emorragico nelle piastrinopenie, Barbul T , Finazzi G (Eds), pp 177–206, Piccin, Padova, 1999.

Heaton W.A.L. Rebulla P. Pappalettera M. Dzik W.H. for the BEST Working Party of the International Society of Blood Transfusion: A comparative analysis of different methods for routine blood component preparation. Transfus Med Rev, 2: 116–129, 1997.

Burgstaler E.A. : Current instrumentation for apheresis. In: Apheresis: principles and practice, McLeod BC , Price TH , Drew MJ (Eds), pp 85–112, AABB Press, Bethesda, 1997.

Zingsem J. Zimmermann R. Weisbach V. Glaser A. van Waeg G. Eckstein R. : Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors. Transfusion, 37: 1045–1049, 1997.

Hauser S.P. Schaller M. Nydegger U.E. : Quality assurance in thrombapheresis. Transfus Sei, 20: 73–77, 1999.

Lopez-Plaza I. Weissfeld J. Triulzi D.J. : The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets. Transfusion, 39: 925–932, 1999.

Carmen R. : The selection of plastic materials for blood bags. Transfus Med Rev, 7: 1–10, 1993.

Gmür J. Burger J. Schanz U. Fehr J. Schaffner A. : Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet, 338: 1223–1226, 1991.

Seymour J. : Prophylactic platelet transfusion in acute leukaemia. Lancet, 339: 120, 1992.

Gmür J. Schaffner A. : Prophylactic platelet transfusion in acute leukaemia. Lancet, 339: 120–121, 1992.

Gil-Fernandez J.J. Alegre A. Fernandez-Villalta M.J. Pinilla I. Gomez Garcia V. Martinez C. Tomas J.F. Arranz R. Figuera A. Camara R. Fernandez-Ranada J.M. : Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant, 18: 931–935, 1996.

Lawrence J.B. Yomtovian R. Hammons T. Masarik S. Lazarus H.M. : Lowering the prophylactic platelet transfusion (Pro-PltTx) trigger: a prospective analysis. Transfusion, 34(Sup-pi), 53S, 1994.

Heckman K.D. Weiner G.J. Davis C.S. Strauss R.G. Jones M.P. Burns C.P. : Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μL versus 20,000/μL. J Clin Oncol, 15: 1143–1149, 1997.

Rebulla P. Finazzi G. Marangoni F. Avvisati G. Gugliotta L. Tognoni G. Barbui T. Mandelli F. Sirchia G. for the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med, 337: 1870–1875, 1997.

Wandt H. Frank M. Ehninger G. Schneider C. Brack N. Daoud A. Fackler-Shwalbe I. Fischer J. Gäckle R. Geer T. Harms P. Löffler B. Ohl S. Otremba B. Raab M. Schönrock-Nabulsi P. Strobel G. Winter R. Link H. : Safety and cost effectiveness of a 10 × 10⁹/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 10⁹/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood, 91: 3601–3606, 1998.

Leverett D. Nulty K. Staves J. Dodds D. Machin S.J. Goldstone A.H. Devereux S. : Clinical and economic effects of lowering the threshold for prophylactic platelet transfusion. Br J Haematol, 105(suppl 1), 30, 1999.

Roy A.J. Jaffe N. Djerassi I. : Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion, 13: 283–290, 1973.

Dutcher J.P. Schiffer C.A. Aisner J. Wiernik P.H. : Alloimmunization following platelet transfusion: the absence of a dose response relationship. Blood, 57: 395–398, 1981.

Strauss R.G. : Clinical perspectives of platelet transfusions: defining the optimal dose. J Clin Apheresis, 10: 124–127, 1995.

Herman J.H. Klumpp T.R. Christman R.A. Russo R.R. Goldberg S.L. Mangan K.F. : The effect of platelet dose on the outcome of prophylactic platelet transfusion (abstract). Transfusion, 35(suppl): 46S, 1995.

Norol F. Bierling P. Roudot-Thoraval F. Ferrer Le Coeur F. Rieux C. Lavaux A. Kuentz M. Duedari N. : Platelet transfusion: a dose-response study. Blood, 92: 1448–1453, 1998.

Hersh J.K. Horn E.G. Brecher M.E. : Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient. Transfusion, 38: 637–644, 1998.

Klumpp T.R. Herman J.H. Gaughan J.P. Russo R.R. Christman R.A. Goldberg S.L. Ackerman S.J. Bleecker G.C. Mangan K.F. : Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion, 39: 674–681, 1999.